KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Inventory (2016 - 2025)

Historic Inventory for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $2.2 billion.

  • Biogen's Inventory fell 1188.38% to $2.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year decrease of 1188.38%. This contributed to the annual value of $2.2 billion for FY2025, which is 1188.38% down from last year.
  • Per Biogen's latest filing, its Inventory stood at $2.2 billion for Q4 2025, which was down 1188.38% from $2.2 billion recorded in Q3 2025.
  • In the past 5 years, Biogen's Inventory ranged from a high of $3.0 billion in Q3 2023 and a low of $1.2 billion during Q1 2021
  • Over the past 5 years, Biogen's median Inventory value was $1.8 billion (recorded in 2022), while the average stood at $1.9 billion.
  • As far as peak fluctuations go, Biogen's Inventory soared by 11690.18% in 2023, and later plummeted by 1720.76% in 2024.
  • Over the past 5 years, Biogen's Inventory (Quarter) stood at $1.4 billion in 2021, then dropped by 0.53% to $1.3 billion in 2022, then skyrocketed by 87.99% to $2.5 billion in 2023, then fell by 2.65% to $2.5 billion in 2024, then decreased by 11.88% to $2.2 billion in 2025.
  • Its Inventory was $2.2 billion in Q4 2025, compared to $2.2 billion in Q3 2025 and $2.3 billion in Q2 2025.